Status: current, Primitive. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554881000168119 | Cabenuva Cabotegravir (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4554891000168116 | Cabenuva Cabotegravir | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabenuva Cabotegravir | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TP | True | Cabenuva Cabotegravir | Inferred relationship | Some | |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | True | Cabenuva Cabotegravir | Inferred relationship | Some | |
| Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial | has TP | True | Cabenuva Cabotegravir | Inferred relationship | Some | |
| Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial | Is a | True | Cabenuva Cabotegravir | Inferred relationship | Some | |
| Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial | has TP | True | Cabenuva Cabotegravir | Inferred relationship | Some | |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TP | True | Cabenuva Cabotegravir | Inferred relationship | Some |
Reference Sets
FHIR